Cisplatin, methotrexate and mitoxantrone in patients with metastatic or advanced urothelial cancer

Acta Oncol. 1998;37(1):110-2. doi: 10.1080/028418698423276.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma, Transitional Cell / drug therapy*
  • Carcinoma, Transitional Cell / mortality
  • Cisplatin / administration & dosage
  • Female
  • Humans
  • Male
  • Methotrexate / administration & dosage
  • Middle Aged
  • Mitoxantrone / administration & dosage
  • Treatment Outcome
  • Urologic Neoplasms / drug therapy*
  • Urologic Neoplasms / mortality

Substances

  • Mitoxantrone
  • Cisplatin
  • Methotrexate